John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Oppenheimer Holdings
OPY
$1.24B
| $2.98M | 0.01% |
68,425
+44,825
| +190% | +$1.96M |
|
1152
Domo
DOMO
$177M
| $2.97M | 0.01% |
58,675
-53,319
| -48% | -$2.42M |
|
1153
Alto Ingredients
ALTO
$325M
| $2.96M | 0.01% |
+434,766
| New | +$2.43M |
|
1154
Oil States International
OIS
$501M
| $2.96M | 0.01% |
425,787
+304,586
| +251% | +$1.93M |
|
|
SWI
1155
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.96M | 0.01% |
+222,275
| New | +$2.93M |
|
1156
Affiliated Managers Group
AMG
$9.28B
| $2.96M | 0.01% |
20,966
+18,597
| +785% | +$2.67M |
|
1157
Quince Therapeutics
QNCX
$34.1M
| $2.95M | 0.01% |
2,381
-606
| -20% | -$825K |
|
|
AGR
1158
DELISTED
Avangrid, Inc.
AGR
| $2.95M | 0.01% |
+63,043
| New | +$2.89M |
|
|
CS
1159
DELISTED
Credit Suisse Group
CS
| $2.94M | 0.01% |
+374,586
| New | +$3.33M |
|
1160
Cracker Barrel
CBRL
$1.3B
| $2.92M | 0.01% |
24,602
+22,702
| +1,195% | +$2.82M |
|
1161
Red Robin
RRGB
$191M
| $2.92M | 0.01% |
173,061
-48,799
| -22% | -$788K |
|
1162
Boyd Gaming
BYD
$5.89B
| $2.89M | 0.01% |
43,981
-335,722
| -88% | -$21.8M |
|
1163
IDEAYA Biosciences
IDYA
$3.86B
| $2.89M | 0.01% |
+258,329
| New | +$3.81M |
|
|
CCEC
1164
Capital Clean Energy Carriers
CCEC
$1.38B
| $2.87M | 0.01% |
157,387
+13,847
| +10% | +$219K |
|
1165
Brink's
BCO
$4.65B
| $2.86M | 0.01% |
+42,097
| New | +$2.88M |
|
1166
Watts Water Technologies
WTS
$12.4B
| $2.85M | 0.01% |
+20,404
| New | +$3.2M |
|
|
TCDA
1167
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.84M | 0.01% |
345,460
-21,930
| -6% | -$198K |
|
1168
BioAtla
BCAB
$5.46M
| $2.84M | 0.01% |
11,349
+7,731
| +214% | +$3.23M |
|
1169
Laureate Education
LAUR
$5.14B
| $2.83M | 0.01% |
239,134
-283,464
| -54% | -$3.44M |
|
1170
Ultragenyx Pharmaceutical
RARE
$2.54B
| $2.83M | 0.01% |
+38,900
| New | +$2.71M |
|
1171
SandRidge Energy
SD
$519M
| $2.82M | 0.01% |
+176,055
| New | +$2.27M |
|
1172
Hims & Hers Health
HIMS
$7.25B
| $2.82M | 0.01% |
528,398
-517,563
| -49% | -$2.56M |
|
1173
StoneX
SNEX
$8.17B
| $2.81M | 0.01% |
+191,484
| New | +$2.66M |
|
|
FBC
1174
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.81M | 0.01% |
66,165
+31,968
| +93% | +$1.47M |
|
1175
Horizon Technology Finance
HRZN
$326M
| $2.8M | 0.01% |
201,582
+43,238
| +27% | +$652K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.